Home/ Stocks/ ORMP

Oramed Pharmaceuticals Inc.

ORMP XNAS

$4.30 +0.00 (+0.00%) ▲ 15-min delayed

Open

$4.30

High

$4.38

Low

$4.28

Volume

110.5K

Market Cap

$178.87M

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 13 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$2.00M	$64.02M	$1.53
FY 2025	$2.00M	$64.02M	$1.53
Q3 2025	$0	$48.39M	$1.16
Q2 2025	$0	$13.26M	$0.32

Related Market News

No specific coverage for ORMP yet. Check out our latest market news or earnings calendar.

Get ORMP Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Oramed Pharmaceuticals Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.